Endurant Capital Management LP Takeda Pharmaceutical CO LTD Transaction History

Endurant Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $14.1 Million - $31.6 Million	1,102,280 New	1,102,280 $14.3 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $2.28 Million - $3.04 Million	-156,120 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $2.03 Million - $3.17 Million	156,120 New	156,120 $2.37 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $1.56 Million - $1.92 Million	-92,273 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $13.6 Million - $15.1 Million	-840,694 Reduced 90.11%	92,273 $1.59 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $8.22 Million - $10.2 Million	495,531 Added 113.28%	932,967 $16.5 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $7.31 Million - $9.41 Million	437,436 New	437,436 $8.91 Million

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.